(Q28249111)

https://api.crossref.org/works/10.1517/14728214.12.3.479

Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Adenosine receptors as therapeutic targets

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Molecular cloning and characterization of the human A3 adenosine receptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Highlights on the development of A(2A) adenosine receptor agonists and antagonists

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Shaping of monocyte and macrophage function by adenosine receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728214.12.3.479

Adenosine A2A agonists in development for the treatment of inflammation

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Subclasses of external adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Signalling from adenosine receptors to mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Tissue distribution of adenosine receptor mRNAs in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Astrocytic purinergic signaling coordinates synaptic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Cell biology. Purinergic chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

New insights into the regulation of inflammation by adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

New antiarrhythmic drugs for prevention of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Paroxysmal supraventricular tachycardia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Pharmacology and therapeutic applications of A1 adenosine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Tecadenoson: a novel, selective A1 adenosine receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Emerging drugs for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Emerging therapies for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Emerging drugs in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Pharmacologic stress testing: new methods and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Advances in pharmacologic agents in imaging: new A2A receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

The case for population-based screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Allosteric modulation of the adenosine family of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Increased nociceptive response in mice lacking the adenosine A1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Emerging drugs for diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

A glance at adenosine receptors: novel target for antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479

(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.479